FDA Action Plan Puts Focus on AI-Enabled Software As Medical Device
The agency plans to take a "multi-pronged approach" to advancing oversight of machine learning-enabled devices – with an eye toward ensuring patient safety, algorithm transparency and real-world results. The AI/ML-Based Software as a Medical Device Action Plan is a project of the Digital Health Center of Excellence at FDA's Center for Devices and Radiological Health, which launched this past September.